サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555547

フェノバルビタール市場：タイプ別、剤形別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Phenobarbital Market, By Type, By Dosage Form, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フェノバルビタール市場：タイプ別、剤形別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

フェノバルビタール市場規模は2023年に15億9,032万米ドルとなり、2024年から2032年にかけてCAGR 5.10％で拡大

フェノバルビタール市場- 市場力学

てんかん有病率の増加が市場需要を促進する見込み

世界のてんかん罹患率の増加は、フェノバルビタールなどの抗てんかん薬需要の増加に大きく寄与しています。てんかんは、発作の再発が特徴的な神経学的疾患であり、患者数が増加しているため、効果的な治療法の必要性が高まっています。世界保健機関（WHO）によると、てんかんに罹患している患者は世界で約5,000万人に上り、最も広く蔓延している神経疾患のひとつとなっています。特に、てんかん患者の80％近くが中低所得国に居住しています。さらに、新興国地域でのヘルスケアインフラの強化や認知度の向上は、市場拡大の新たな機会をもたらす可能性があります。しかし、特定の地域では認知度が限られているため、市場成長の妨げになる可能性があります。

フェノバルビタール市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.10%のCAGRで毎年成長すると予測されています。

タイプ別セグメンテーションでは、てんかんが2023年に最大市場シェアを示すと予測されています。

剤形別では、2023年には錠剤が主要タイプになりました。

地域別では、北米が2023年に収益でリードしました。

フェノバルビタール市場-セグメンテーション分析：

世界のフェノバルビタール市場は、タイプ、剤形、用途、地域に基づいて区分されます。

市場はタイプによって2つのセグメントに分類される：てんかん」と「新生児発作」の2つに分類され、「てんかん」が市場シェアをリードしています。フェノバルビタールは、新生児てんかんを含む小児てんかんの治療に頻繁に使用されており、その有効性と安全性が実証されています。

市場は剤形によって3つのカテゴリーに分類される：錠剤、カプセル剤、注射剤です。錠剤は市場をリードするカテゴリーです。フェノバルビタール錠剤は、医薬品市場、特にてんかん治療において確固たる地位を築いています。

市場は用途別に3つに区分される：病院薬局、小売薬局、オンライン薬局です。どのチャネルも、患者の要望や状況に応じた方法でこの必要な医薬品を入手することを保証する上で重要な役割を担っています。

フェノバルビタール市場-地理的洞察

フェノバルビタール市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカにまたがっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。北米が市場をリードしているのは、主に事故による外傷性脳損傷の増加によるものです。特に米国とカナダでは、北米では交通事故、スポーツ、転倒、その他の事故による外傷性脳損傷の発生が多いです。これらの傷害はしばしば発作を引き起こし、それによってフェノバルビタールのような効果的な抗てんかん治療に対する需要が増加しています。米国疾病予防管理センターは、2021年には米国で69,000人以上のTBI関連死が発生すると予測しており、これは1日当たり約190人のTBI関連死に相当します。欧州は、製剤の進歩に起因する市場成長で2番目に大きい地域を保持しています。

フェノバルビタール市場-競合情勢：

フェノバルビタール市場の競合情勢は、製薬企業間の敵対関係、ジェネリック医薬品の存在、市場動向など、さまざまな要因によって形成されています。フェノバルビタールの生産では、市場で豊富な歴史を持つ主要企業が主要プレーヤーです。これらの企業は、徐放錠や併用療法などの革新的な製剤や投与システムを導入することで、市場シェアを争う可能性があります。競合は今後も、入手可能性、価格、市場全体のダイナミクスを決定する上で重要な役割を果たすと思われます。

目次

第1章 フェノバルビタール市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 フェノバルビタールの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 フェノバルビタール産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 フェノバルビタール市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 フェノバルビタール市場情勢

  • フェノバルビタール市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 フェノバルビタール市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • てんかん
    • 新生児発作

第8章 フェノバルビタール市場- 剤形別

  • 概要
    • 剤形別セグメントシェア分析
    • 錠剤
    • カプセル
    • 注射

第9章 フェノバルビタール市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 フェノバルビタール市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- フェノバルビタール業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Sanofi
    • Pfizer Inc.
    • Novartis AG
    • H.Lundbeck A/S
    • Teva pharmaceuticals Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals
    • Cipla Ltd.
    • Par Pharmaceutical
    • Mylan NV
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3585

REPORT HIGHLIGHT

Phenobarbital Market size was valued at USD 1,590.32 million in 2023, expanding at a CAGR of 5.10% from 2024 to 2032.

Phenobarbital, a member of the barbiturate drug class, has a wide range of therapeutic uses. It is effective in managing seizures and treating status epilepticus, and insomnia. Additionally, it plays a crucial role in addressing benzodiazepine and alcohol withdrawal symptoms. Phenobarbital is utilized for seizure control, anxiety relief, and prevention of withdrawal symptoms in individuals dependent on other barbiturate medications. Belonging to the class of barbiturates, Phenobarbital functions by slowing down brain activity.

Phenobarbital Market- Market Dynamics

The increasing prevalence of epilepsy is expected to propel market demand

The growing incidence of epilepsy across the globe significantly contributes to the rising demand for antiepileptic drugs, such as phenobarbital. Epilepsy, a prevalent neurological condition marked by recurrent seizures, is experiencing an increase in cases, thereby intensifying the need for effective treatment alternatives. According to the World Health Organization, approximately 50 million individuals worldwide are affected by epilepsy, making it one of the most widespread neurological disorders. Notably, nearly 80% of those with epilepsy reside in low- and middle-income countries. Additionally, the enhancement of healthcare infrastructure and increased awareness in developing regions may present new opportunities for market expansion. However, limited awareness in certain areas could hinder market growth.

Phenobarbital Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.10% over the forecast period (2024-2032)

Based on Type segmentation, Epilepsy was predicted to show maximum market share in the year 2023

Based on Dosage Form segmentation, Tablets was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Phenobarbital Market- Segmentation Analysis:

The Global Phenobarbital Market is segmented based on Type, Dosage Form, Application, and Region.

The market is categorized into two segments based on Type: Epilepsy and Neonatal Seizures, with the Epilepsy segment leading in market share. Phenobarbital is frequently utilized in the management of pediatric epilepsy, including cases involving newborns experiencing seizures, owing to its proven efficacy and safety when administered judiciously.

The market is segmented into three categories according to Dosage Form: Tablets, Capsules, and Injectable. Tablets are the leading category in the market. Phenobarbital tablets have a strong foothold in the pharmaceutical market, particularly in the management of epilepsy.

The market is segmented into three categories according to Application: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Every channel has a crucial part in guaranteeing that patients obtain this necessary medication in a way that accommodates their requirements and situations.

Phenobarbital Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the countries involved in business activities. North America leads the market, primarily due to the rising number of traumatic brain injuries caused by accidents. Particularly in the United States and Canada, North America witnesses high occurrences of traumatic brain injuries resulting from road accidents, sports, falls, and other incidents. These injuries often lead to seizures, thereby increasing the demand for effective antiepileptic treatments such as phenobarbital. The Centers for Disease Control and Prevention projected that there will be more than 69,000 TBI-related deaths in the United States in 2021, equating to approximately 190 TBI-related deaths per day. Europe holds the second-largest market region for growth, attributed to advancements in formulations.

Phenobarbital Market- Competitive Landscape:

The competitive landscape of the phenobarbital market is shaped by a variety of factors, such as the rivalry among pharmaceutical companies, the existence of generic options, and market trends. Leading pharmaceutical companies with a rich history in the market are key players in the production of phenobarbital. These companies may vie for market share by introducing innovative formulations or delivery systems like extended-release tablets or combination treatments. Competition will continue to play a crucial role in determining the availability, pricing, and overall dynamics of the market as it progresses.

Recent Developments:

Pfizer Inc. made an announcement nowadays regarding the approval of PAXLOVID (nirmatrelvir tablets and ritonavir tablets) by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19, such as hospitalization or death.

On February 5, 2024, Novartis disclosed its decision to engage in a voluntary public takeover bid to acquire MorphoSys AG, a biopharmaceutical company headquartered in Germany that specializes in the development of groundbreaking oncology treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHENOBARBITAL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • H.Lundbeck A/S
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals
  • Cipla Ltd.
  • Par Pharmaceutical
  • Mylan N.V.
  • Others

GLOBAL PHENOBARBITAL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Epilepsy
  • Neonatal Seizures

GLOBAL PHENOBARBITAL MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Capsules
  • Injectable

GLOBAL PHENOBARBITAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL PHENOBARBITAL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Phenobarbital Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Phenobarbital Market Snippet by Type
    • 2.1.2. Phenobarbital Market Snippet by Dosage Form
    • 2.1.3. Phenobarbital Market Snippet by Application
    • 2.1.4. Phenobarbital Market Snippet by Country
    • 2.1.5. Phenobarbital Market Snippet by Region
  • 2.2. Competitive Insights

3. Phenobarbital Key Market Trends

  • 3.1. Phenobarbital Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Phenobarbital Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Phenobarbital Market Opportunities
  • 3.4. Phenobarbital Market Future Trends

4. Phenobarbital Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Phenobarbital Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Phenobarbital Market Landscape

  • 6.1. Phenobarbital Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Phenobarbital Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Epilepsy
    • 7.1.3. Neonatal Seizures

8. Phenobarbital Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules
    • 8.1.4. Injectable

9. Phenobarbital Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Phenobarbital Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Phenobarbital Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Phenobarbital Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Phenobarbital Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Phenobarbital Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Phenobarbital Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Phenobarbital Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Sanofi
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Novartis AG
    • 11.2.4. H.Lundbeck A/S
    • 11.2.5. Teva pharmaceuticals Industries Ltd.
    • 11.2.6. Sun Pharmaceutical Industries Ltd.
    • 11.2.7. Hikma Pharmaceuticals
    • 11.2.8. Cipla Ltd.
    • 11.2.9. Par Pharmaceutical
    • 11.2.10. Mylan N.V.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us